Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Prevalence OR# of musculoskeletal complaints (MSCs) related to fasting serum glucose, HbA1c and duration of the disease in patients with DM

From: The association between diabetes mellitus, glucose, and chronic musculoskeletal complaints. Results from the Nord-Trøndelag Health Study

Variables Total Chronic MSCs Chronic widespread MSCs Chronic non-widespread MSCs
  1940 % OR (CI) % OR (CI) % OR (CI)
Serum glucose        
≤6.3 mmol/l 482 59.3 1.0 (reference) 6.4 1.0 (reference) 52.9 1.0 (reference)
6.4–8.7 mmol/l 487 55.2 0.8 (0.6–1.1) 5.1 0.7 (0.4–1.2) 50.1 0.8 (0.6–1.1)
8.8–12.1 mmol/l 472 54.9 0.8 (0.6–1.1) 6.1 0.8 (0.5–1.4) 48.7 0.8 (0.6–1.1)
≥12.2 mmol/l 469 57.4 1.0 (0.7–1.3) 6.4 1.0 (0.6–1.8) 51.0 1.0 (0.7–1.3)
Missing 30 70.0 1.2 (0.5–3.0) 0.0 - 70.0 1.5 (0.6–3.6)
HbA1c        
≤6.8 mmol/l 509 57.2 1.0 (reference) 6.7 1.0 (reference) 50.5 1.0 (reference)
6.9–7.8 mmol/l 422 59.2 1.1 (0.9–1.5) 5.0 0.8 (0.4–1.5) 54.3 1.2 (0.9–1.5)
7.9–9.2 mmol/l 481 55.7 1.0 (0.7–1.2) 5.2 0.8 (0.5–1.4) 50.5 1.0 (0.8–1.3)
≥9.3 mmol/l 426 53.8 0.9 (0.7–1.2) 7.0 1.0 (0.6–1.7) 46.7 0.9 (0.7–1.2)
Missing 102 64.7 1.4 (0.9–2.1) 4.9 0.8 (0.3–2.4) 59.8 1.4 (0.9–2.3)
Duration of DM
≤2 years 502 56.2 1.0 (reference) 6.4 1.0 (reference) 49.8 1.0 (reference)
3–6 years 360 56.4 1.0 (0.8–1.4) 4.7 0.8 (0.4–1.4) 51.7 1.1 (0.8–1.4)
7–13 years 403 57.1 1.1 (0.8–1.4) 6.0 1.1 (0.6–2.1) 51.1 1.1 (0.8–1.5)
≥14 years 406 59.1 1.2 (0.9–1.6) 6.9 1.6 (0.9–2.8) 52.2 1.2 (0.9–1.6)
Missing 269 55.4 1.0 (0.7–1.3) 5.2 1.0 (0.5–2.1) 50.2 1.0 (0.7–1.3)
  1. # Adjusted for age, gender, body mass index, and level of physical activity
  2. $ Serum glucose treated as a single ordinal variable (categories 1 to 4 based on quartiles)
  3. §Serum glucose treated as a continuous variable (β value given in brackets)